1-10210698-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001365951.3(KIF1B):c.-260C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0018 in 151,528 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0018 ( 2 hom., cov: 32)
Exomes 𝑓: 0.015 ( 0 hom. )
Consequence
KIF1B
NM_001365951.3 5_prime_UTR
NM_001365951.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.25
Publications
0 publications found
Genes affected
KIF1B (HGNC:16636): (kinesin family member 1B) Predicted to enable microtubule binding activity and plus-end-directed microtubule motor activity. Predicted to be involved in chemical synaptic transmission; dense core granule cytoskeletal transport; and vesicle-mediated transport. Predicted to act upstream of or within mitochondrion transport along microtubule. Predicted to be located in cytoplasmic vesicle membrane and neuron projection. Predicted to be part of kinesin complex. Predicted to be active in several cellular components, including axon; dendrite; and microtubule. Implicated in Charcot-Marie-Tooth disease type 2A1; carcinoma (multiple); multiple sclerosis; neuroblastoma; and pheochromocytoma. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
KIF1B Gene-Disease associations (from GenCC):
- pheochromocytomaInheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth disease type 2A1Inheritance: AD Classification: SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neuroblastoma, susceptibility to, 1Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BS2
High AC in GnomAd4 at 269 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIF1B | NM_001365951.3 | c.-260C>T | 5_prime_UTR_variant | Exon 1 of 49 | ENST00000676179.1 | NP_001352880.1 | ||
KIF1B | NM_183416.4 | c.-260C>T | 5_prime_UTR_variant | Exon 1 of 21 | NP_904325.2 | |||
KIF1B | NM_015074.3 | c.-260C>T | upstream_gene_variant | NP_055889.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00178 AC: 269AN: 151218Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
269
AN:
151218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0147 AC: 3AN: 204Hom.: 0 AF XY: 0.0197 AC XY: 3AN XY: 152 show subpopulations
GnomAD4 exome
AF:
AC:
3
AN:
204
Hom.:
AF XY:
AC XY:
3
AN XY:
152
show subpopulations
African (AFR)
AF:
AC:
0
AN:
2
American (AMR)
AF:
AC:
0
AN:
4
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AF:
AC:
0
AN:
10
South Asian (SAS)
AF:
AC:
0
AN:
2
European-Finnish (FIN)
AF:
AC:
0
AN:
2
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
3
AN:
174
Other (OTH)
AF:
AC:
0
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00178 AC: 269AN: 151324Hom.: 2 Cov.: 32 AF XY: 0.00185 AC XY: 137AN XY: 73958 show subpopulations
GnomAD4 genome
AF:
AC:
269
AN:
151324
Hom.:
Cov.:
32
AF XY:
AC XY:
137
AN XY:
73958
show subpopulations
African (AFR)
AF:
AC:
14
AN:
41462
American (AMR)
AF:
AC:
24
AN:
15128
Ashkenazi Jewish (ASJ)
AF:
AC:
28
AN:
3466
East Asian (EAS)
AF:
AC:
1
AN:
5172
South Asian (SAS)
AF:
AC:
45
AN:
4830
European-Finnish (FIN)
AF:
AC:
8
AN:
10244
Middle Eastern (MID)
AF:
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
AC:
141
AN:
67726
Other (OTH)
AF:
AC:
5
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3362
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Pheochromocytoma Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neuroblastoma Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Charcot-Marie-Tooth disease type 2 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.